Sepsis represents an important global health burden due to its high mortality and morbidity. The rapid detection of sepsis is crucial in order to prevent adverse outcomes and reduce mortality. However, the diagnosis of sepsis is still challenging and many efforts have been made to identify reliable biomarkers. Unfortunately, many investigated biomarkers have several limitations that do not support their introduction in clinical practice, such as moderate diagnostic and prognostic accuracy, long turn-around time, and high-costs. Complete blood count represents instead a precious test that provides a wealth of information on individual health status. It can guide clinicians to early-identify patients at high risk of developing sepsis and to predict adverse outcomes. It has several advantages, being cheap, easy-to-perform, and available in all wards, from the emergency department to the intensive care unit. Noteworthy, it represents a first-level test and an alteration of its parameters must always be considered within the clinical context, and the eventual suspect of sepsis must be confirmed by more specific investigations. In this review, we describe the usefulness of basic and new complete blood count parameters as diagnostic and prognostic biomarkers of sepsis.

Agnello, L., Giglio, R.V., Bivona, G., Scazzone, C., Gambino, C.M., Iacona, A., et al. (2021). The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis [10.3390/diagnostics11101881].

The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis

Agnello, Luisa;Giglio, Rosaria Vincenza;Bivona, Giulia;Scazzone, Concetta;Gambino, Caterina Maria;Iacona, Alessandro;Ciaccio, Anna Maria;Lo Sasso, Bruna;Ciaccio, Marcello
2021-10-12

Abstract

Sepsis represents an important global health burden due to its high mortality and morbidity. The rapid detection of sepsis is crucial in order to prevent adverse outcomes and reduce mortality. However, the diagnosis of sepsis is still challenging and many efforts have been made to identify reliable biomarkers. Unfortunately, many investigated biomarkers have several limitations that do not support their introduction in clinical practice, such as moderate diagnostic and prognostic accuracy, long turn-around time, and high-costs. Complete blood count represents instead a precious test that provides a wealth of information on individual health status. It can guide clinicians to early-identify patients at high risk of developing sepsis and to predict adverse outcomes. It has several advantages, being cheap, easy-to-perform, and available in all wards, from the emergency department to the intensive care unit. Noteworthy, it represents a first-level test and an alteration of its parameters must always be considered within the clinical context, and the eventual suspect of sepsis must be confirmed by more specific investigations. In this review, we describe the usefulness of basic and new complete blood count parameters as diagnostic and prognostic biomarkers of sepsis.
Settore BIO/12 - Biochimica Clinica E Biologia Molecolare Clinica
https://www.mdpi.com/2075-4418/11/10/1881
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534992/
Agnello, L., Giglio, R.V., Bivona, G., Scazzone, C., Gambino, C.M., Iacona, A., et al. (2021). The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis [10.3390/diagnostics11101881].
File in questo prodotto:
File Dimensione Formato  
The Value of a Complete Blood Count (CBC) for Sepsis.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 907.95 kB
Formato Adobe PDF
907.95 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/556694
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact